Search Results
Found 50 results for "Irish Pharma" across articles, medicines, trials, companies and the glossary
Industry
From Lab Bench to DeltaV: The Highest-Paying Tech & Automation Roles in Irish Biomanufacturing
An analysis of the digital transformation reshaping Irish biomanufacturing. How hybrid skills in DeltaV, Manufacturing Execution Systems (MES), SCADA, and AI-driven process engineering command a 35% salary premium across Dublin and Cork facilities.
Industry
Daily Rate vs. Salary in Irish Pharma: Is Contracting Still the Fastest Route to Wealth in 2026?
A quantitative financial comparison between permanent corporate employment and daily-rate contracting in Ireland's biopharmaceutical sector. Examining €550 to €850 daily rates, umbrella company setups, tax efficiencies, pension strategies, and job security.
Industry
The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany
An in-depth salary and purchasing power analysis for Ireland's life sciences sector. Comparing gross €100k+ compensation packages against progressive marginal taxes, housing rent, and net disposable income in Dublin and Cork versus Basel, Munich, and Copenhagen.
Industry
The Qualified Person (QP) Arms Race: Why Irish Biopharma Is Paying Up to €180,000 to Retain Regulatory Talent
An inside examination of Ireland's acute shortage of Qualified Persons (QPs) and regulatory leaders. Exploring why multinational biopharma hubs in Cork and Dublin are offering packages up to €180,000 and retention bonuses to safeguard commercial batch release.
Industry
Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
An in-depth analysis of Ireland's €93.8 billion pharmaceutical and medical exports to non-EU markets. Examining trade data across the United States, UK, Switzerland, and Asia-Pacific, key manufacturing clusters in Cork, Dublin, and Limerick, and the strategic outlook for 2026.
Industry
The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery
As direct-to-patient dispensing platforms like LillyDirect expand across the UK and digital healthcare alters prescription delivery, community pharmacists in Ireland and Great Britain are adapting. This critical analysis examines the impact of mail-order platforms, recent regulatory shifts in Ireland, and how local chemists are pivoting to clinical primary care services.
Industry
Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
An in-depth evaluation of Donald Trump’s scheduled September visit to Ireland, examining the Doonbeg Irish Open itinerary, security logistics, protectionist tariffs, corporate tax policy friction, and strategic implications for U.S.-Irish bilateral relations.
Industry
The Cost-Governed Enterprise: A Financial Governance Playbook for AI in Irish Life Sciences
MIT research found that 95% of enterprise generative AI pilots show no measurable P&L impact, despite up to €36.8bn of global investment. The failure is not the technology, it is governance: cost is billed and legible, return is diffuse and uninstrumented. A seven-band cost taxonomy, eight load-bearing equations and the make-versus-rent crossover that Irish life sciences boards need to close the gap.
Industry
US Pharmaceutical Tariffs Update: Policy Realities, The Stockpile 'Unwind', and Ireland’s Strategic Position
An in-depth analysis of where US pharmaceutical tariff policies stand in mid-2026 under the Trump administration, analyzing recent CSO export data, inventory stockpiling corrections, MFN agreements, and Ireland’s strategic biopharma position.
Industry
High Expectations, Historic Opportunity: What Ireland’s Rotating EU Council Presidency Can Deliver for European and Irish Pharma
A Priya Life Science White Paper analyzing the pivotal policy dossiers of the 2026 Irish Presidency, the economic stakes for biopharma manufacturing, and key strategic recommendations.
Industry
ABPI Impact Map Highlights £20.4B Pharma Footprint as UK-Ireland Supply Chain Synergies Deepen
The ABPI launches its updated 2026 Pharmaceutical Impact Map, revealing a £20.4bn economic contribution, 125,702 skilled jobs, and 3,658 NHS collaborations across the UK, while underscoring vital cross-border manufacturing and trade synergies with Ireland.
Industry
Master the Ireland & EU Pharma CV in 2026: HPRA Standards, ATS Templates & Industry Examples
The definitive 2026 guide to writing an ATS-compliant biopharmaceutical CV in Ireland and the EU. Features HPRA & EU Annex 1 standards, GxP bullet point formulas, Irish regional hub insights, and free ATS CV Studio tools.
Regulatory Affairs
After the Mother of All Deals: A Blueprint for the Ireland-India Pharmaceutical Corridor Under the EU-India FTA
A commercial-grade blueprint for the Ireland-India pharma corridor under the EU-India FTA: tariffs, HPRA-CDSCO bridges, 2030 projections, policy asks.
Regulatory Affairs
Addressing the 801-Day Lag: Ireland’s Drug Approval System Demands Urgent Structural Reform
The latest EFPIA Patients W.A.I.T. Indicator report reveals that Irish patients wait an average of 801 days to access newly approved medicines, prompting calls for an overhaul of the HSE and NCPE reimbursement processes and a dedicated mechanism for rare disease orphan drugs.
Pharmaceutical
The Anatomy of a Biologics Warning Letter: Deconstructing Genzyme Waterford’s FDA Audit
The FDA CBER warning letter issued to Genzyme Ireland’s Waterford site in June 2026 is a watershed moment for Irish biopharma. From 11x repeated filter tests to discarded checklists and unexplained deviation cancellations, we analyze the specific CGMP violations and detail what this compliance failure means for quality management across the sector.
Biotechnology
The Dublin-Backed Roll-Up Reshaping UK Pharma Packaging: Inside Woodberry's Double Acquisition
In a deal announced on July 7, 2026, Woodberry Packaging - the Dublin-backed packaging group led by veteran entrepreneur Patrick Doran - has acquired Medica Packaging, the UK's largest independent pharmaceutical carton converter, and F.G. Curtis, a respected name in cosmetics and personal care packaging. The combined group now employs 650 people across the UK and Ireland with revenues exceeding €120 million, marking a significant consolidation moment in the specialist packaging sector.
Regulatory Affairs
Data Integrity and Quality Oversight: Analyzing the FDA Warning Letter for Sanofi's Waterford Site
Following a January 2026 inspection, the FDA has issued a formal warning letter to Genzyme Ireland Limited in Waterford, citing data integrity concerns, uncontrolled checklists, and quality unit oversight gaps in the manufacturing of Thymoglobulin and Altuviiio.
Pharmaceutical
The Irish Distortion: How Multinational Pharma Giants Warped the EU’s Economic Landscape
Ireland’s status as a corporate hub for global pharmaceutical multinationals has created a unique statistical paradox-masking true economic health and dragging the EU’s GDP into negative territory in the first quarter of 2026. We examine the tax structures, tariff-hedging inventory builds, and supply chain strategies driving this anomaly.
Biotechnology
Life Science PR in 2026: The Complete Guide to Building Authority, Winning Media Coverage, and Controlling Your Narrative
A definitive 5,000-word guide to public relations for pharmaceutical, biotech, and MedTech professionals. Learn how to build a PR strategy from scratch, which tools to use, how to write for journalists and LinkedIn, and the exact frameworks used by the world's leading life science communications teams.
Industry
Navigating Ireland’s Pharma Dependency: Strategies for Policy and Talent in an Uncertain Era
With pharmaceuticals making up 20% of Ireland’s GDP, the nation’s reliance on the industry brings immense economic benefit but notable risks. We explore how Ireland must adapt its policy, manage geopolitical headwinds, and aggressively attract skilled labour to secure its future.
Regulatory Affairs
Beyond the Headline: Are Irish Pharma Workers Truly the Highest Paid in Europe?
Recent reports suggest Irish pharma workers are the highest paid in Europe, but a deeper dive reveals a more complex reality. We analyze compensation packages, tax regimes, and cost of living across Europe’s top pharmaceutical hubs.
Industry
Egypt, Ireland Explore Industrial Cooperation in Pharmaceuticals, Renewable Energy, and Advanced Technologies
Egypt’s Minister of Industry and Ireland’s Ambassador discuss strategic collaboration across pharmaceuticals, renewable energy, and technology sectors, aiming to leverage Irish expertise for local manufacturing.
Industry
Viewpoint: Why Ireland’s Pharma Sector is Immune to the Global 'Carbon Leakage' Exodus
A new Central Bank of Ireland study reveals that while global manufacturers flee strict climate laws, Ireland's biopharma sector remains stubbornly rooted. Here is what this means for the future of Irish FDI.
Industry
Irish Universities Association Launches Strategy 2026-2030 to Navigate Technological and Global Shifts
The IUA has unveiled its ambitious five-year strategy, built around five core priorities: Advocacy, Alignment, Agility, Access, and Accountability, aimed at securing the future of Ireland's higher education sector.
MedTech
Leading Digital Transformation in Ireland’s Pharma Sector: 5 Ways to Overcome Middle Management Resistance to AI
As Ireland’s pharma sector pivots toward Industry 4.0, middle management resistance to AI is a critical bottleneck. Here are 5 root causes of this pushback and targeted strategies to align your teams and drive digital transformation.
Pharmaceutical
Roche Seeks Buyer for Former Manufacturing Site in Clarecastle, Co Clare - €4m Price Tag
Swiss pharma giant Roche has appointed Cushman & Wakefield to sell its 88-acre decommissioned manufacturing facility in Clarecastle, Co Clare, with an expected asking price of €4 million, following a €150m remediation programme.
LinkedIn
LinkedIn for Medical Science Liaisons (MSLs): The Complete Guide to Showcasing Scientific Expertise Without Violating Compliance
A step-by-step compliance-safe LinkedIn guide exclusively for Medical Science Liaisons. Covers profile optimisation, what to post, what never to post, KOL engagement, off-label rules, digital medical affairs strategy, and how to build scientific credibility on LinkedIn without breaching pharmaceutical regulatory guidelines.
Regulatory Affairs
How to Build a Powerful Personal Brand in Pharma Without Sharing Proprietary Data
A complete step-by-step guide for pharmaceutical, biotech and life science professionals on building a credible, visible personal brand on LinkedIn - without ever crossing compliance lines or risking proprietary data exposure. Covers brand strategy, content pillars, storytelling frameworks, and the exact boundaries every pharma professional must respect.
Pharmaceutical
The Cascade Effect: How US MFN and IRA Pricing Mandates Are Reshaping Drug Development, Launch Sequencing, and Ireland’s Life Sciences Sector
An in-depth analysis of how US Most Favored Nation (MFN) drug pricing proposals and the Inflation Reduction Act (IRA) are forcing pharmaceutical companies to restructure indication sequencing, ex-US launches, and global supply chains.
Industry
Beyond the Strait: How the US-Iran Peace Deal Will Reshape Ireland’s Pharmaceutical Value Chains in 2026
With the US-Iran peace deal signed and the Strait of Hormuz set to reopen, Ireland's pharmaceutical export sector stands to benefit from stabilized global energy tariffs, normalized maritime trade corridors, and renewed multinational capital inflows.
Pharmaceutical
Enterprise Ireland Reports Record €38.86bn in Exports: What It Means for Indigenous Life Sciences
Enterprise Ireland has announced record total exports of €38.86 billion. With the Advanced Manufacturing and Life Sciences sector surging by 14% to €13.16 billion, we analyse what this means for Ireland's homegrown pharma ecosystem.
Pharmaceutical
Ireland in the Crosshairs: How New U.S. Tax Rules and Trade Policies Threaten the Irish Pharma Boom
New U.S. disclosure regulations and aggressive "America First" trade policies from the Trump administration have exposed the massive tax payments of U.S. pharmaceutical giants in Ireland, placing the country's fiscal stability under intense scrutiny.
LinkedIn
How to Create a LinkedIn Profile Using AI: The 2026 Guide for Life Science Professionals
Step-by-step guide to building a standout LinkedIn profile using ChatGPT and AI tools - written for pharma, biotech, and MedTech professionals in Ireland. Includes copy-paste AI prompts for every section.
Regulatory Affairs
Landmark Agreements on Medicine Pricing and Supply Target 180-Day Turnaround by 2029
The Irish government signs major new Framework Agreements with MFI and IPHA, aiming to reduce patient wait times for innovative treatments to 180 days by 2029.
Biotechnology
Rare Disease Bottlenecks vs. Encouraging Clinical Trial Growth in Ireland
Despite encouraging growth in clinical trial activity, patients in Ireland face an average wait of 801 days for access to rare disease medicines, prompting calls for urgent systemic reform.
MedTech
EU-India FTA: A New Era of Trade Creating a 2 Billion People Free Trade Zone
Discover how the monumental EU-India Free Trade Agreement creates a market of 2 billion people. Explore its impact on tech, education, and how it will specifically propel Ireland's pharmaceutical and life sciences sector.
LinkedIn
Setting Up Your LinkedIn Profile for Pharma and Life Science in Ireland
A complete step-by-step guide to building a LinkedIn profile that gets noticed by recruiters in Ireland's pharma, biotech, and MedTech sectors. Learn how to optimize your headline, write a compelling About section, and highlight FDA/HPRA compliance experience.
Pharmaceutical
From Powerhouse to Pioneer: How Ireland's Life Science Sector Is Pivoting from Manufacturing to an R&D-Led Innovation Hub in 2026
An in-depth analysis of Ireland's National Life Science Innovation Strategy in 2026. We examine the structural challenges of this transition-including specialised R&D infrastructure, the acute talent shortage in cell and gene therapies (CGT), and how digital compliance tools like Priya LifePDF streamline the transition.
MedTech
The Digital-First Regulatory Landscape: How Ireland's Life Science Sector Is Adapting to the EU AI Act, EHDS, and Governance by Design
A comprehensive guide for Irish pharmaceutical, MedTech, and life science professionals on the EU AI Act implementation, the European Health Data Space, cGMP compliance in an AI-driven environment, ALCOA+ in digital systems, and the practical steps organisations must take to achieve governance by design in 2026.
MedTech
AI Tools for Life Science and Pharma 2026: ChatGPT vs Claude vs Gemini vs Perplexity, Complete Pricing Guide and Decision Framework
A complete 2026 guide for pharmaceutical and life science professionals on choosing the right AI tool. Detailed pricing breakdown, comparison tables, regulatory guidance (FDA, EU GMP, ICH Q10, HPRA), and a step-by-step decision framework for QA/QC, regulatory affairs, and R&D teams.
Regulatory Affairs
Democratizing Pharma Compliance: How Priya LifeScience is Empowering Ireland's Biotech and Pharmaceutical Sectors with Free, Open-Source, and 100% Private Digital Utilities
Priya LifeScience is on a mission to democratize compliance, quality assurance, and documentation in Ireland's pharmaceutical and biotech sectors by providing 100% free, open-source, browser-native digital utilities.
Regulatory Affairs
Free GMP Document Stamp Tool for Irish Pharma: Apply APPROVED, DRAFT and CONTROLLED COPY to PDFs Without Cloud Upload
Irish pharma, MedTech and life science teams can now apply GMP-standard status stamps to pharmaceutical PDFs entirely in their browser - with zero file upload, zero server, and full compliance with GDPR Article 25, EU GMP Annex 1, FDA 21 CFR Part 11, and HPRA requirements.
Regulatory Affairs
Why GMP Document Status Stamps Are a Regulatory Requirement: FDA, EU GMP Annex 1 and HPRA Guide for Ireland
APPROVED, DRAFT, CONTROLLED COPY, SUPERSEDED - these are not just labels. Under FDA 21 CFR Part 11, EU GMP Annex 1, ICH Q10, and HPRA requirements, visible document status marking is a regulatory obligation. Here is the complete guide for Irish pharma and life science professionals.
Industry
Why Eli Lilly's €2 Billion Bet on Limerick is a Career Game-Changer for Irish Pharma
Eli Lilly has committed over €2 billion to its Raheen biomanufacturing campus - the largest single pharma investment in Irish history. Here's what it means for your career in 2026.
Regulatory Affairs
Irish Pharma Salary Guide 2026: What QC Analysts, Engineers and Bioprocess Operators Are Earning
Comprehensive salary benchmarks for life science professionals in Ireland. From QC Analysts (€42k-€62k) to Senior Validation Engineers (€80k-€110k) - know your worth before your next interview.
Industry
How to Get Your First Pharma Job in Ireland in 2026: The Complete Step-by-Step Guide
A practical, no-nonsense guide for science graduates and career changers looking to break into Ireland's world-class pharmaceutical and MedTech sector in 2026.
LinkedIn
10 LinkedIn Profile Fixes That Will Get You Noticed by Irish Pharma Recruiters in 2026
Irish pharma recruiters scan hundreds of profiles daily. These 10 targeted optimisations will push your profile to the top of their shortlist - and most take under 10 minutes to implement.
Pharmaceutical
How the Iran Conflict Is Disrupting Ireland’s Pharmaceutical Industry and Why It Matters Globally.
Middle East air route disruptions are raising costs and delaying Ireland’s pharma exports, impacting global medicine supply chains.
LinkedIn
How to Set Up Your LinkedIn Profile for Pharma Jobs in Ireland
Optimize your LinkedIn profile with pharma specific keywords, skills, and Ireland-focused positioning to increase visibility and attract recruiter opportunities.
Pharmaceutical
Ireland’s Pharmaceutical Export Decline in 2026: A Data-Driven Analysis of Emerging Trade Shifts
Ireland’s pharma exports fell 35% in Jan 2026, driven by a sharp decline in US shipments. Explore causes, trends, and global life sciences impact.